GoldenGolden
Imago BioSciences Inc

Imago BioSciences Inc

Imago BiosSciences is a clinical-stage therapeutics company developing treatments for malignant and life-threatening diseases for bone marrow.

Imago BioSciences is a biotechnology and clinical-stage therapeutics company developing drugs to improve the management of proliferative disease of the bone marrow.

Timeline

November 19, 2020
Imago BioSciences Inc raises a $80,000,000 series C round from Farallon Capital Management, Greenspring Associates, Highlight Capital, Kingdon Capital, MRL Ventures Fund, Omega Funds, Pharmaron Holding, Surveyor Capital, T. Rowe Price and Xeraya Capital.
March 2019
Imago BioSciences Inc raises a $40,000,000 series B round from Amgen Ventures, Frazier Healthcare Partners, Greenspring Associates, Highlight Capital, MRL Ventures Fund, Omega Funds and Pharmaron Holding.
October 31, 2014
Imago BioSciences Inc raises a $26,500,000 series A round from Amgen Ventures, Clarus Ventures and Frazier Healthcare Partners.
2012
Imago BioSciences Inc was founded by Hugh Rienhoff.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.